Blog Category:

Unraveling the Complexities of cUTI Care: Modernizing cUTI Care with the 2025 IDSA and EAU Updates

Complicated urinary tract infections (cUTIs) represent an important and growing challenge in clinical practice, affecting individual patients’ health and quality of life while exerting a substantial burden on the healthcare system. Despite being common, these infections are underrecognized. The July …

ASCVD Risk Decision Aid to Inform Lipid-Lowering Therapy

New guidance from the National Lipid Association emphasizes the need for simpler risk stratification and establishing LDL-C goals. Clinicians have had mixed guidance on LDL-C management and desirable lipid goals until now.   We are in a new, more metabolically …

From Pain to Progress: Guiding Providers Through Opioid Stewardship

Chronic, subacute, and acute pain remain among the most common and complex challenges encountered in clinical practice. Inadequate pain management contributes to diminished quality of life, impaired function, and increased healthcare utilization. At the same time, the ongoing opioid crisis …

Cracking the Code in PBC: Interactive Escape Room for Specialists

Embark on a one-of-a-kind learning adventure designed to sharpen your diagnostic skills and treatment prowess for primary biliary cholangitis (PBC). In this immersive virtual escape room, you’ll tackle patient case challenges, uncover hidden clues, and piece together the key insights …

Preventing the Preventable: Improving Mycophenolate Practices in Patients of Childbearing Potential

Mycophenolate-containing medications are potent immunosuppressants used to prevent organ transplant rejection and to treat (off label) some autoimmune disorders. Despite the well-documented fetal risks associated with mycophenolate, as outlined in the U.S. Food and Drug Administration’s (FDA’s) Mycophenolate Risk Evaluation …